|
Christopher Perkin joined Charles River Laboratories in October 2004 upon the completion of the merger with Inveresk Research Group where he served as Chief Operating Officer at CTBR Bio-Research Inc. a subsidiary of Inveresk. In December 2004 Mr. Perkin was named President Canadian Preclinical Services and in October 2005 Corporate Vice President. In June 2007 under Mr. Perkin�s direction Charles River established preclinical operations in China.
Mr. Perkin received his BSc degree from Bradford University | 